Although this product is not sold in the u.S.This event is being reported under regulations 21 cfr part 803 as it involves a similar device to a pma approved device sold in the u.S.Under #p070014.The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specifications prior to shipment.As part of all complaint investigations, an attempt was made to evaluate the subject device as well as the device usage.In this case, no sample was returned.The evaluation of the image provided confirmed a constriction of the stent in the middle section.The strut material accumulation and deformation indicates a stent twisting.Potential factors that could have led or contributed to the reported event have been evaluated.Previous investigation of similar complaints have been reviewed.A twisting of this kind of stent may be caused by interactions of various use-related and anatomical factors with the given stent design.Also various physical forces including individual patient factors may contribute to the twisting of a stent in this region.The reported application represents an of-label use of the device, which is considered another contributing factor to the reported event.On the basis of the information available, a definite root cause for the reported event could not be determined.The ifu supplied with the device sufficiently describes the correct deployment of the stent.The ifu states that the lifestent vascular stent is indicated for primary stenting of de-novo or restenotic lesions of peripheral arteries.The safety and effectiveness of the device for a treatment as described has not be established.
|